Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Class I recall for pacemakers | Open heart surgery performed mid-delivery | AHA supports NIH | Semaglutide shortage ends
Monday, February 24, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary

These safety issues have been linked to more than 800 injuries and two deaths. It is possible, the FDA warned, that some patients may require a device to be removed and replaced. 

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
These safety issues have been linked to more than 800 injuries and two deaths. It is possible, the FDA warned, that some patients may require a device to be removed and replaced. 
READ MORE >

Surgeons first in world to perform open heart surgery on baby mid-delivery

The baby had been diagnosed with an especially challenging case of hypoplastic left heart syndrome.

READ MORE >
A baby in New York underwent open heart surgery for hypoplastic left heart syndrome as it was being delivered in what is believed to be the first operation of its kind.
Share on Twitter Share on Facebook Share on Linkedin

Surgeons first in world to perform open heart surgery on baby mid-delivery

Share on Twitter Share on Facebook Share on Linkedin
A baby in New York underwent open heart surgery for hypoplastic left heart syndrome as it was being delivered in what is believed to be the first operation of its kind.
The baby had been diagnosed with an especially challenging case of hypoplastic left heart syndrome.
READ MORE >

American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

READ MORE >
heart data research doctor cardiologist AI
Share on Twitter Share on Facebook Share on Linkedin

American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

Share on Twitter Share on Facebook Share on Linkedin
heart data research doctor cardiologist AI
“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 
READ MORE >

FDA ends semaglutide shortage, closing the door on compounded Wegovy, Ozempic

The years-long shortage of Wegovy and Ozempic, two popular prescription-only semaglutide injections, is officially over. 

READ MORE >
Semaglutide (Wegovy) injector pen. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

FDA ends semaglutide shortage, closing the door on compounded Wegovy, Ozempic

Share on Twitter Share on Facebook Share on Linkedin
Semaglutide (Wegovy) injector pen. Photo by Dave Fornell
The years-long shortage of Wegovy and Ozempic, two popular prescription-only semaglutide injections, is officially over. 
READ MORE >

Featured Articles

Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

READ MORE >
approval regulations checkmark doctor
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist questions FDA’s approval process for high-risk medical devices

Share on Twitter Share on Facebook Share on Linkedin
approval regulations checkmark doctor
The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.
READ MORE >

Embracing the future: James Min left academia to push for a paradigm shift in preventive cardiology

James Min, MD, Cleerly's founder and CEO, changed careers to address what he saw as a major unmet need in cardiology.

READ MORE >
Video of James Min, MD, explaining the future of cardiac care using CT and AI plaque analysis to create a personalized and more accurate cardiac risk assessment, similar to a mammogram for the heart.
Share on Twitter Share on Facebook Share on Linkedin

Embracing the future: James Min left academia to push for a paradigm shift in preventive cardiology

Share on Twitter Share on Facebook Share on Linkedin
Video of James Min, MD, explaining the future of cardiac care using CT and AI plaque analysis to create a personalized and more accurate cardiac risk assessment, similar to a mammogram for the heart.
James Min, MD, Cleerly's founder and CEO, changed careers to address what he saw as a major unmet need in cardiology.
READ MORE >

FDA approves first rapid-acting insulin biosimilar for diabetes

Sanofi's Merilog is a new biosimilar substitute for Novo Nordisk’s NovoLog. It can be used to treat adult and pediatric patients with type 1 and type 2 diabetes.

READ MORE >
Sugar Insulin
Share on Twitter Share on Facebook Share on Linkedin

FDA approves first rapid-acting insulin biosimilar for diabetes

Share on Twitter Share on Facebook Share on Linkedin
Sugar Insulin
Sanofi's Merilog is a new biosimilar substitute for Novo Nordisk’s NovoLog. It can be used to treat adult and pediatric patients with type 1 and type 2 diabetes.
READ MORE >

Getinge ending production of cardiopulmonary surgical perfusion systems

The global medtech company is also looking to expand its organ transplant and ECMO portfolios.

READ MORE >
Getinge says it is ending production of its cardio-pulmonary surgical perfusion product in 2025, but plans to invest more in its Maquet Cardiosave ECMO system, which has continued market growth. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

Getinge ending production of cardiopulmonary surgical perfusion systems

Share on Twitter Share on Facebook Share on Linkedin
Getinge says it is ending production of its cardio-pulmonary surgical perfusion product in 2025, but plans to invest more in its Maquet Cardiosave ECMO system, which has continued market growth. Photo by Dave Fornell
The global medtech company is also looking to expand its organ transplant and ECMO portfolios.
READ MORE >

In Case You Missed It

COVID-19 linked to accelerated plaque growth, long-term risk of heart attack or stroke

These risks appear to be present regardless of a person's age or health at the time of infection.

READ MORE >
A heart attack is caused when one of the coronary arteries becomes blocked with a clot.
Share on Twitter Share on Facebook Share on Linkedin

COVID-19 linked to accelerated plaque growth, long-term risk of heart attack or stroke

Share on Twitter Share on Facebook Share on Linkedin
A heart attack is caused when one of the coronary arteries becomes blocked with a clot.
These risks appear to be present regardless of a person's age or health at the time of infection.
READ MORE >

Post-stroke follow-up care considerably worse for women than men

Female stroke survivors are less likely to receive a cardiology referral or undergo cardiac monitoring than their male counterparts.

READ MORE >
older female patient and doctor
Share on Twitter Share on Facebook Share on Linkedin

Post-stroke follow-up care considerably worse for women than men

Share on Twitter Share on Facebook Share on Linkedin
older female patient and doctor
Female stroke survivors are less likely to receive a cardiology referral or undergo cardiac monitoring than their male counterparts.
READ MORE >

THT 2025: Late-breaking clinical trials announced for CRF’s heart failure conference

The annual conference is now in its fourth year. Attendees are encouraged to leave their ties, jackets and skirts at home and embrace a more casual dress code.

READ MORE >
women doctors
Share on Twitter Share on Facebook Share on Linkedin

THT 2025: Late-breaking clinical trials announced for CRF’s heart failure conference

Share on Twitter Share on Facebook Share on Linkedin
women doctors
The annual conference is now in its fourth year. Attendees are encouraged to leave their ties, jackets and skirts at home and embrace a more casual dress code.
READ MORE >

In Other News

Mummies, dinosaurs and vikings—CT is becoming the modality of choice to study history

Experts are interested in using computed tomography as an investigative tool due to its ability to provide detailed information while also preserving historical artifacts. 

READ MORE >
Researchers use CT scans to study Viking skulls.
Share on Twitter Share on Facebook Share on Linkedin

Mummies, dinosaurs and vikings—CT is becoming the modality of choice to study history

Share on Twitter Share on Facebook Share on Linkedin
Researchers use CT scans to study Viking skulls.
Experts are interested in using computed tomography as an investigative tool due to its ability to provide detailed information while also preserving historical artifacts. 
READ MORE >

Chinese companies accused of conspiring to steal imaging trade secrets from Philips

Xiaoqin Du, 63, of Suzhou, China, allegedly formed a rival firm in the same Chicago suburb as Philips, luring away engineers to relay intimate company details. 

READ MORE >
Philips Headquarters
Share on Twitter Share on Facebook Share on Linkedin

Chinese companies accused of conspiring to steal imaging trade secrets from Philips

Share on Twitter Share on Facebook Share on Linkedin
Philips Headquarters
Xiaoqin Du, 63, of Suzhou, China, allegedly formed a rival firm in the same Chicago suburb as Philips, luring away engineers to relay intimate company details. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup